It is unclear what mechanism(s) are behind the sex differences of these immune cell populations, although modulation of Grn expression in the rodent brain by sex hormones has been reported [101], and in humans, there are known sex differences in the prevalence of neurodegenerative conditions, such as FTD–GRN, AD, and PD [102–104]. Here, GRN is linked to Parkinson disease.